- Ownership
-
Zogenix, Inc. Insider Trading
* In original currency USD
Loading Data
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
---|---|---|---|---|---|---|---|---|
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | U-Tender | D | 1,250 | 26.00 USD | 32,500 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 9,375 | 24.56 USD | 230,250 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 6,250 | 15.52 USD | 97,000 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 9,000 | 12.80 USD | 115,200 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 10,000 | 8.99 USD | 89,900 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 20,000 | 12.75 USD | 255,000 USD |
Monday, March 7th, 2022 | BREITMEYER JAMES B | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | Stutts Mary E. | director | 0 | D-Return | D | 20,000 | 22.82 USD | 456,400 USD |
Monday, March 7th, 2022 | Stutts Mary E. | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | BOCK LOUIS C | director | 0 | D-Return | D | 9,000 | 12.80 USD | 115,200 USD |
Monday, March 7th, 2022 | BOCK LOUIS C | director | 0 | D-Return | D | 20,000 | 8.99 USD | 179,800 USD |
Monday, March 7th, 2022 | BOCK LOUIS C | director | 0 | D-Return | D | 20,000 | 12.75 USD | 255,000 USD |
Monday, March 7th, 2022 | BOCK LOUIS C | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | TANNENBAUM RENEE P | director | 0 | U-Tender | D | 32,567 | 26.00 USD | 846,742 USD |
Monday, March 7th, 2022 | TANNENBAUM RENEE P | director | 0 | D-Return | D | 3,000 | 12.80 USD | 38,400 USD |
Monday, March 7th, 2022 | TANNENBAUM RENEE P | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | U-Tender | D | 16,606 | 26.00 USD | 431,756 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 30,289 | 13.96 USD | 422,834 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 14,250 | 13.32 USD | 189,810 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 45,000 | 10.35 USD | 465,750 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 52,500 | 10.20 USD | 535,500 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 35,000 | 27.36 USD | 957,600 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 30,000 | 18.76 USD | 562,800 USD |
Monday, March 7th, 2022 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 40,187 | 0.00 USD | 0 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | U-Tender | D | 25,022 | 26.00 USD | 650,572 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 53,125 | 24.16 USD | 1,283,500 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 8,125 | 16.64 USD | 135,200 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 28,125 | 10.64 USD | 299,250 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 28,500 | 13.32 USD | 379,620 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 60,000 | 10.35 USD | 621,000 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 60,000 | 10.20 USD | 612,000 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 39,000 | 27.36 USD | 1,067,040 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 30,000 | 18.76 USD | 562,800 USD |
Monday, March 7th, 2022 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 45,499 | 0.00 USD | 0 USD |
Monday, March 7th, 2022 | Loewy Caroline M | director | 0 | D-Return | D | 20,000 | 22.82 USD | 456,400 USD |
Monday, March 7th, 2022 | Loewy Caroline M | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | GARNER CAM L | director | 0 | U-Tender | D | 40,843 | 26.00 USD | 1,061,918 USD |
Monday, March 7th, 2022 | GARNER CAM L | director | 0 | D-Return | D | 20,000 | 8.99 USD | 179,800 USD |
Monday, March 7th, 2022 | GARNER CAM L | director | 0 | D-Return | D | 20,000 | 12.75 USD | 255,000 USD |
Monday, March 7th, 2022 | GARNER CAM L | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | U-Tender | D | 92,806 | 26.00 USD | 2,412,956 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 87,499 | 15.04 USD | 1,315,985 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 69,373 | 15.92 USD | 1,104,418 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 43,749 | 24.56 USD | 1,074,475 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 26,583 | 10.64 USD | 282,843 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 93,750 | 11.04 USD | 1,035,000 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 90,767 | 10.35 USD | 939,438 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 85,937 | 10.20 USD | 876,557 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 165,000 | 27.36 USD | 4,514,400 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 93,335 | 18.76 USD | 1,750,965 USD |
Monday, March 7th, 2022 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 128,955 | 0.00 USD | 0 USD |
Monday, March 7th, 2022 | Waynick Denelle J | director | 0 | U-Tender | D | 584 | 26.00 USD | 15,184 USD |
Monday, March 7th, 2022 | Waynick Denelle J | director | 0 | D-Return | D | 20,000 | 22.82 USD | 456,400 USD |
Monday, March 7th, 2022 | Waynick Denelle J | director | 0 | D-Return | D | 22,000 | 17.83 USD | 392,260 USD |
Monday, November 29th, 2021 | TANNENBAUM RENEE P | director | 32,567 | S-Sale | D | 5,305 | 11.72 USD | 62,175 USD |
Tuesday, August 10th, 2021 | GARNER CAM L | director | 41,000 | P-Purchase | A | 10,000 | 14.83 USD | 148,298 USD |
Monday, August 9th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 5,000 | A-Award | A | 5,000 | 0.00 USD | 0 USD |
Tuesday, June 1st, 2021 | TANNENBAUM RENEE P | director | 37,872 | P-Purchase | A | 5,000 | 17.05 USD | 85,247 USD |
Tuesday, June 1st, 2021 | Waynick Denelle J | director | 584 | P-Purchase | A | 584 | 17.07 USD | 9,969 USD |
Thursday, May 27th, 2021 | BREITMEYER JAMES B | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | Waynick Denelle J | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | GARNER CAM L | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | BOCK LOUIS C | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | Loewy Caroline M | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | Stutts Mary E. | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Thursday, May 27th, 2021 | TANNENBAUM RENEE P | director | 22,000 | A-Award | A | 22,000 | 17.83 USD | 392,260 USD |
Monday, May 10th, 2021 | GARNER CAM L | director | 31,000 | P-Purchase | A | 15,000 | 19.03 USD | 285,496 USD |
Friday, March 26th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 18.76 USD | 562,800 USD |
Friday, March 26th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 15,000 | A-Award | A | 15,000 | 0.00 USD | 0 USD |
Friday, March 26th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 93,335 | A-Award | A | 93,335 | 18.76 USD | 1,750,965 USD |
Friday, March 26th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 46,665 | A-Award | A | 46,665 | 0.00 USD | 0 USD |
Friday, March 26th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 30,000 | A-Award | A | 30,000 | 18.76 USD | 562,800 USD |
Friday, March 26th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 15,000 | A-Award | A | 15,000 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 22,258 | M-Exempt | A | 1,625 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,803 | F-InKind | D | 455 | 20.70 USD | 9,418 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,202 | M-Exempt | A | 2,031 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 20,633 | F-InKind | D | 569 | 20.70 USD | 11,778 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,609 | M-Exempt | A | 1,562 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,171 | F-InKind | D | 438 | 20.70 USD | 9,067 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,875 | M-Exempt | D | 1,625 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,062 | M-Exempt | D | 2,031 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 1,562 | M-Exempt | D | 1,562 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 93,212 | M-Exempt | A | 6,875 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 90,834 | F-InKind | D | 2,378 | 20.70 USD | 49,225 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 88,066 | M-Exempt | A | 5,000 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 86,337 | F-InKind | D | 1,729 | 20.70 USD | 35,790 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 84,795 | M-Exempt | A | 5,000 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 83,066 | F-InKind | D | 1,729 | 20.70 USD | 35,790 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 20,625 | M-Exempt | D | 6,875 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 15,000 | M-Exempt | D | 5,000 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | FARR STEPHEN J | director, officer: President and CEO | 5,000 | M-Exempt | D | 5,000 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 15,318 | M-Exempt | A | 1,500 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 14,776 | F-InKind | D | 542 | 20.70 USD | 11,219 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 14,553 | M-Exempt | A | 2,031 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 13,818 | F-InKind | D | 735 | 20.70 USD | 15,214 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 13,109 | M-Exempt | A | 1,625 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 12,522 | F-InKind | D | 587 | 20.70 USD | 12,151 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 4,500 | M-Exempt | D | 1,500 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 4,062 | M-Exempt | D | 2,031 | 0.00 USD | 0 USD |
Monday, March 15th, 2021 | Farfel Gail M | officer: EVP/Chief Development Officer | 1,625 | M-Exempt | D | 1,625 | 0.00 USD | 0 USD |